Altogether, the present data indicate that HCC with nuclear SKP2 translocation are often characterized by activation of the AKT/mTOR and Ras/MAPK pathways, with β-catenin mutations and/or activation rarely occurring in this HCC subset. This evidence concerns the gene MTOR and hepatocellular carcinoma.